17-50982647-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001130528.3(SPAG9):āc.3114T>Cā(p.Tyr1038Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,610,730 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0090 ( 24 hom., cov: 32)
Exomes š: 0.00093 ( 29 hom. )
Consequence
SPAG9
NM_001130528.3 synonymous
NM_001130528.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.816
Genes affected
SPAG9 (HGNC:14524): (sperm associated antigen 9) This gene encodes a member of the cancer testis antigen gene family. The encoded protein functions as a scaffold protein that structurally organizes mitogen-activated protein kinases and mediates c-Jun-terminal kinase signaling. This protein also binds to kinesin-1 and may be involved in microtubule-based membrane transport. This protein may play a role in tumor growth and development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 17-50982647-A-G is Benign according to our data. Variant chr17-50982647-A-G is described in ClinVar as [Benign]. Clinvar id is 717062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.816 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00902 (1374/152304) while in subpopulation AFR AF= 0.0318 (1322/41558). AF 95% confidence interval is 0.0304. There are 24 homozygotes in gnomad4. There are 636 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1374 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPAG9 | NM_001130528.3 | c.3114T>C | p.Tyr1038Tyr | synonymous_variant | 25/30 | ENST00000262013.12 | NP_001124000.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPAG9 | ENST00000262013.12 | c.3114T>C | p.Tyr1038Tyr | synonymous_variant | 25/30 | 1 | NM_001130528.3 | ENSP00000262013.7 |
Frequencies
GnomAD3 genomes AF: 0.00898 AC: 1366AN: 152186Hom.: 24 Cov.: 32
GnomAD3 genomes
AF:
AC:
1366
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00222 AC: 547AN: 246796Hom.: 9 AF XY: 0.00156 AC XY: 208AN XY: 133338
GnomAD3 exomes
AF:
AC:
547
AN:
246796
Hom.:
AF XY:
AC XY:
208
AN XY:
133338
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000928 AC: 1354AN: 1458426Hom.: 29 Cov.: 30 AF XY: 0.000775 AC XY: 562AN XY: 725354
GnomAD4 exome
AF:
AC:
1354
AN:
1458426
Hom.:
Cov.:
30
AF XY:
AC XY:
562
AN XY:
725354
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00902 AC: 1374AN: 152304Hom.: 24 Cov.: 32 AF XY: 0.00854 AC XY: 636AN XY: 74476
GnomAD4 genome
AF:
AC:
1374
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
636
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at